In ovarian cancer, YBX1 recognizes m5C-modified CHD3 mRNA and maintains its stability by recruiting the RNA-binding protein PABPC1, thereby enhancing homologous recombination (HR) repair and promoting resistance to platinum-induced apoptosis [39]. Here, CHD3 is linked to ovarian carcinoma.